Core Viewpoint - The company West Point Pharmaceutical (301130) announced that its director and deputy general manager, Shi Yingxiu, plans to reduce his holdings by no more than 442,200 shares, which represents 0.5781% of the company's total share capital and 22.4971% of his personal holdings [1] Summary by Relevant Sections - Share Reduction Plan - Shi Yingxiu intends to reduce his shareholding through centralized bidding transactions within three months after the announcement date [1] - The maximum number of shares to be reduced is 442,200 [1] - Ownership Impact - The planned reduction accounts for 0.5781% of the total share capital of the company [1] - This reduction represents 22.4971% of Shi Yingxiu's total shareholdings in the company [1]
西点药业：石英秀拟减持不超0.5781%公司股份